The future of health is hidden in your microbiome and we at ENBIOSIS guide you to find what is hidden in your guts.
Producing scientific inventions, products, and services by using microbiome organisms, we aim to improve the quality of human health. With our artificial intelligence-powered technologies, we analyze the human gut microbiome in order to provide personalized health solutions that cover a special microbiome diet program and prebiotics.
WHAT WE DO?
ENBIOSIS Biotechnology combines artificial intelligence and microbiome science to provide personalized health solutions. We analyze health parameters using an artificial intelligence technology-based personalized recommendation system.
Trillions of gut bacteria in our enhanced database are analyzed with the help of advanced artificial intelligence models. We offer a personalized nutrition program and prebiotics based on the results of the gut microbiome analysis.
The ENBIOSIS ecosystem consists of a vast network of users, connected via our biobank, mobile, and wearable-tech; an artificial-intelligence operating system constantly mining the biobank big data to invent and offer health solutions to the users; the bioscience team conducting research on microbiome science to develop integrated biotech products and services; and a network of health professionals consulting the users.
Serial entrepreneur, Renewable energy, Artificial intelligence, Biotechnology
Bilkent University IE
Prof. Dr. Dr. André Gessner
Scientific Advisory Board Member
The director of the Institute for medical microbiology and hygiene at the University of Regensburg and a member of the University of Regensburg.
Ph.D. Ufuk Nalbantoğlu
Co-founder – CTO
15 years of experience research. Principal investigator of NIH, NFS, and DTRA funded projects. Built the bioinformatics software of Earth Microbiome Projects
Assoc. Prof. Aycan Gündoğdu
Co-founder – CSO
The national laboratories of the Sunshine Coast, Queensland Department of Health, and CSIRO, Head scientists of Turkish National Microbiome Project, EU Human Microbiome Studies committee member
Varol TUNALI MD, PhD
Strong scientific background and international experience. Focused on scientific leadership and medical guidance.
Eurofins Scientific is an international laboratory group that analyzes pharmaceuticals, food, environment and agricultural products and provides support services to governments with its expert team and extensive technology portfolio.
Eurofins Scientific has become one of the world’s leading providers of genomics services, thanks to its high product quality, customer-oriented service and innovative developments in genomic research.
The cooperation with Eurofins gives us access to its advanced network of labs, clinics and hospitals, while also allowing European healthcare providers to use our services conveniently and effectively.
AKESOgen is an integrated genomics, genetics and biobanking company that services the pharmaceutical, biotechnology, clinical, academic, and government sectors for clinical trials, diagnostic clinical testing and research. Based in greater Atlanta, GA, the company’s initial focus has been oncology and personalized medicine.
AKESOgen is a partner of ENBIOSIS for all services in USA and a premier provider of Genetic Analysis Contract Research and Clinical Diagnostic and Clinical Trial Services for Pharmaceutical, Biotech, Academic and Government Research Institutions.
Producing scientific inventions, products, and services that will improve the quality of human health by using microbiome organisms.
Making health solutions accessible to the masses by prioritizing the principles of human development.